Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study

• DOI: 10.1053/euhj.2001.3033
• Publication Date: 2002-07-28T21:50:54Z
• Authors: S Coccheri
• Keywords: Claudication; Intermittent claudication; Placebo-controlled study

Aims Patients with peripheral arterial obstructive disease require treatment to prevent major cardiovascular events and relieve intermittent claudication. The walking performance of patients was used evaluate the usefulness sulodexide, a glycosaminoglycan containing fast moving heparin dermatan sulphate.